sacituzumab
gilead
['sacituzumab', 'mbc', 'tropics-02', 'sacitu, govi']
tropics-02 phase 3 trial analysis presented by #komen scholar showed highly pretreated patients with hormonal receptor positive #mbc had improvement in overall survival and progression free survival for sacituzumab govitecan over physician s choice #asco23 
A force united by a promise to end breast cancer, funding groundbreaking research, community health & advocacy programs globally.
https://t.co/dvoS7vv1mZ